104 related articles for article (PubMed ID: 12874604)
1. Altered immunoreactive levels of G proteins in peripheral mononuclear cells of patients with anorexia nervosa and bulimia nervosa.
Monteleone P; Di Lieto A; Martiadis V; Pannuto M; Maj M
Mol Psychiatry; 2003 Jul; 8(7):680-4. PubMed ID: 12874604
[TBL] [Abstract][Full Text] [Related]
2. Reduced Gs protein function and G alpha s levels in leukocytes of patients with Parkinson's disease.
Avissar S; Barki-Harrington L; Herishanu Y; Schreiber G
Mov Disord; 1997 Mar; 12(2):167-74. PubMed ID: 9087974
[TBL] [Abstract][Full Text] [Related]
3. Enhanced serum cholesterol and triglyceride levels in bulimia nervosa: relationships to psychiatric comorbidity, psychopathology and hormonal variables.
Monteleone P; Santonastaso P; Pannuto M; Favaro A; Caregaro L; Castaldo E; Zanetti T; Maj M
Psychiatry Res; 2005 Apr; 134(3):267-73. PubMed ID: 15892986
[TBL] [Abstract][Full Text] [Related]
4. Phosducin-like protein levels in leukocytes of patients with major depression and in rat cortex: the effect of chronic treatment with antidepressants.
Matuzany-Ruban A; Schreiber G; Farkash P; Avissar S
Psychiatry Res; 2006 Mar; 141(3):287-94. PubMed ID: 16510194
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction.
Heydorn A; Ward RJ; Jorgensen R; Rosenkilde MM; Frimurer TM; Milligan G; Kostenis E
Mol Pharmacol; 2004 Aug; 66(2):250-9. PubMed ID: 15266015
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects.
Monteleone P; Luisi M; De Filippis G; Colurcio B; Monteleone P; Genazzani AR; Maj M
Int J Eat Disord; 2003 Dec; 34(4):432-40. PubMed ID: 14566930
[TBL] [Abstract][Full Text] [Related]
7. Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.
Bodenstein J; Venter DP; Brink CB
J Pharmacol Exp Ther; 2005 Aug; 314(2):891-905. PubMed ID: 15857948
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa.
Monteleone P; Luisi M; Colurcio B; Casarosa E; Monteleone P; Ioime R; Genazzani AR; Maj M
Psychosom Med; 2001; 63(1):62-8. PubMed ID: 11211066
[TBL] [Abstract][Full Text] [Related]
9. Loss of association between activated Galpha q and Gbetagamma disrupts receptor-dependent and receptor-independent signaling.
Evanko DS; Thiyagarajan MM; Takida S; Wedegaertner PB
Cell Signal; 2005 Oct; 17(10):1218-28. PubMed ID: 16038796
[TBL] [Abstract][Full Text] [Related]
10. Cognitive flexibility in anorexia nervosa and bulimia nervosa.
Tchanturia K; Anderluh MB; Morris RG; Rabe-Hesketh S; Collier DA; Sanchez P; Treasure JL
J Int Neuropsychol Soc; 2004 Jul; 10(4):513-20. PubMed ID: 15327730
[TBL] [Abstract][Full Text] [Related]
11. Reduced platelet [3H]paroxetine binding in anorexia nervosa: relationship to eating symptoms and personality pathology.
Bruce KR; Steiger H; Ng Ying Kin NM; Israel M
Psychiatry Res; 2006 Jun; 142(2-3):225-32. PubMed ID: 16697471
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II induced upregulation of G alpha q/11, phospholipase C beta 3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor.
Bai H; Wu LL; Xing DQ; Liu J; Zhao YL
Chin Med J (Engl); 2004 Jan; 117(1):88-93. PubMed ID: 14733781
[TBL] [Abstract][Full Text] [Related]
13. Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa.
Monteleone P; Fabrazzo M; Tortorella A; Martiadis V; Serritella C; Maj M
Psychoneuroendocrinology; 2005 Apr; 30(3):243-50. PubMed ID: 15511598
[TBL] [Abstract][Full Text] [Related]
14. No changes in serum ghrelin levels in female patients with bulimia nervosa.
Nakazato M; Hashimoto K; Shiina A; Koizumi H; Mitsumoti M; Imai M; Shimizu E; Iyo M
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1181-4. PubMed ID: 15610931
[TBL] [Abstract][Full Text] [Related]
15. Eating Disorders Examination versus Eating Disorders Examination-Questionnaire in adolescents with full and partial-syndrome bulimia nervosa and anorexia nervosa.
Binford RB; Le Grange D; Jellar CC
Int J Eat Disord; 2005 Jan; 37(1):44-9. PubMed ID: 15690465
[TBL] [Abstract][Full Text] [Related]
16. The endocrinology of anorexia nervosa and bulimia nervosa.
Thomas MA; Rebar RW
Curr Opin Obstet Gynecol; 1990 Dec; 2(6):831-6. PubMed ID: 2130987
[No Abstract] [Full Text] [Related]
17. Mastoparan inhibits beta-adrenoceptor-G(s) signaling by changing the localization of Galpha(s) in lipid rafts.
Sugama J; Yu JZ; Rasenick MM; Nakahata N
Cell Signal; 2007 Nov; 19(11):2247-54. PubMed ID: 17692506
[TBL] [Abstract][Full Text] [Related]
18. [Somatic complications in anorexia and bulimia nervosa].
Ringskog S
Lakartidningen; 1999 Feb; 96(8):882-6. PubMed ID: 10089732
[TBL] [Abstract][Full Text] [Related]
19. Gustatory and olfactory sensitivity in patients with anorexia and bulimia in the course of treatment.
Aschenbrenner K; Scholze N; Joraschky P; Hummel T
J Psychiatr Res; 2008 Dec; 43(2):129-37. PubMed ID: 18423668
[TBL] [Abstract][Full Text] [Related]
20. Gbetagamma signaling and Ca2+ mobilization co-operate synergistically in a Sos and Rac-dependent manner in the activation of JNK by Gq-coupled receptors.
Chan AS; Wong YH
Cell Signal; 2004 Jul; 16(7):823-36. PubMed ID: 15115661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
